跳至主要内容
临床试验/NCT01313247
NCT01313247Unknown4 期

Optimizing Medication for Cancer Pain. The Effect of Paracetamol. A Clinical and Pharmacological Trial to Research Whether Paracetamol Gives an Additional Effect on Pain Relief When the Patient is Treated With High Doses of Opioids

Haraldsplass Deaconess Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
50
试验地点
1
主要终点
Pain reduction caused by paracetamol 4g/d

研究概览

简要总结

Randomised, double-blind placebo controlled cross-over trial

Main goal:

Optimize the medical pain treatment for patients with advanced cancer disease

Study goal:

Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv. morphine > 100 mg/d.

详细描述

National multicenter study with an intention to include 50 patients. 6 days treatment, 3d in each arm. Mean pain score last 24 h: NRS =/> 4 All drug treatment constant during the study period. The participants are allowed to take as much rescue opioids as necessary to have adequate relief.

Paracetamol/ placebo given orally 1000 mg x 4 daily, three days in each arm, direct crossover.

Daily scoring of pain relief, ESAS, overall satisfaction and rescue medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (> 18 years) of both sexes
  • Diagnosed with advanced cancer disease
  • Ongoing medicinal pain relief treatment in stable dosing with oral opiates equivalent to > 100 mg oral morphine daily
  • NRS median pain score last 24 hrs > 4
  • Able to take tablets (paracetamol) orally

排除标准

  • Mental or physical deficiency precluding data collection.
  • Reduced liver function judged with bilirubin, INR and transaminases
  • Anticoagulation with warfarin
  • Ongoing use of NSAIDs or 5-HT3 antagonists, or use of such drugs last week
  • Ongoing palliative radiation treatment or radiation treatment during the last 4 weeks.

研究组 & 干预措施

Placebo pills

Placebo Comparator

Placebo tablets resembling paracetamol 500 mg are given as alternative 2 tablets 4 times daily

干预措施: placebo tablets (Drug)

oral paracetamol 4 g daily

Active Comparator

Patients are given 2 tablets of 500 mg paracetamol on a regular basis 4 times daily

干预措施: paracetamol (Drug)

结局指标

主要结局

Pain reduction caused by paracetamol 4g/d

时间窗: Last day in each 3 days study period

Pain reduction in the active paracetamol arm, compared to placebo, corrected for difference in rescue medication intake.

次要结局

  • Overall satisfaction with the pain treatment(End of each 3 days study period)

研究者

发起方
Haraldsplass Deaconess Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验